Assignee
TELIOS PHARMA INC
US·2 granted patents·5 pending applications·3 citations·filing 2021–2025
Top patents by PatentIndex Score
7 records- 0191US11642343B2Methods of treating splenomegalyTELIOS PHARMA INC·Filed 2021·Granted May 9, 2023·2 cites·33 claims
- 0281US12414950B1Methods of treating indolent systemic mastocytosisTELIOS PHARMA INC·Filed 2024·Granted Sep 16, 2025·1 cites·26 claims
- 0361US2024024314A1Methods of Treating SplenomegalyTELIOS PHARMA INC·Filed 2021·Application pending·0 cites
- 0461US2026041685A1Methods of treating indolent systemic mastocytosisTELIOS PHARMA INC·Filed 2025·Application pending·0 cites
- 0559US2025064805A1Methods of Treating Myeloproliferative Disorders Based on BTK Occupancy & Resynthesis RateTELIOS PHARMA INC·Filed 2023·Application pending·0 cites
- 0659US2024293403A1Treatment of Symptoms Associated with Myeloproliferative NeoplasmsTELIOS PHARMA INC·Filed 2022·Application pending·0 cites
- 0753US2024000782A1Methods and compositions for treating an ophthalmic conditionTELIOS PHARMA INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TELIOS PHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →